Latest News Archive

Please select Category, Year, and then Month to display items

Nketsa, Summers crowned UFS top student-athletes

24 October 2023 | Story Jóhann Thormählen | Photo Kaleidoscope Studios

Free State Sport Stars 2023 — The University of the Free State (UFS) crowned its top athletes at the Free State Sport Stars dinner. Robert Summers and Refiloe Nketsa were named KovsieSport Sportsman and Sportswoman of the Year. Here, from left, are Temba Hlasho, Executive Director: Student Affairs at the UFS, Summers, Janine de Kock, KovsieSport netball sports officer, on behalf of Nketsa and Teboho Setena, Editor: Express.

In a spectacular celebration of sporting excellence, Refiloe Nketsa, and Robert Summers were bestowed with the highest honours as University of the Free State’s (UFS) Sportswoman and Sportsman of the Year respectively. This prestigious event took place on 12 October 2023 in Bloemfontein, where the KovsieSport awards were presented.

Recognition of remarkable achievements

Nketsa, a Protea netball player, voiced her elation at achieving this pinnacle of her career. She had earlier been a School Sport Star nominee at the Free State Sport Stars in 2019, presented by Central24 and the UFS. Her meteoric rise to senior level has been nothing short of remarkable. Reflecting on her journey, she stated, “Looking at the pool of nominees and all that they’ve achieved, I almost thought I didn’t stand a chance. All I have isn’t because of my doing. Its God ordained.”

Summers, a South African badminton luminary and the UFS Sportsman of the Year for a second consecutive year expressed his gratitude and humility at receiving this prestigious accolade. He highlighted the challenges he faced, including a debilitating injury, making this achievement even more meaningful. Summers added, “It’s incredible having your name on a trophy with the likes of Wayde van Niekerk, CJ van der Linde, and Heinrich Brüssow. Those are big names, and to be on the same trophy is something I will cherish for a long time.”

The Shimla, Michael Annies was named UFS Junior Sportsman of the Year and the triple jumper Johani van Tonder, UFS Junior Sportswoman of the Year.

The highest honour at the Free State Sport Stars went to the former Kovsie Karla Pretorius, crowned Sport Star of the Year.

The Protea netball vice-captain, Pretorius, also received the Sportswoman of the Year and the Protea cricketer Gerald Coetzee the Sportsman of the Year, of the province.

Encouragement and inspiration for the future

Nketsa says it is a big honour being the top UFS sportswoman. She represented the Proteas in the past year and was an official World Cup reserve and vice-captain of the South African side that won a first-ever silver medal at the Fast5 World Series. Nketsa emphasised the motivation this award instils in her, compelling her to intensify her efforts in improving her work ethic and skills.

Likewise, Summers despite his challenges, finds this award to be a silver lining, inspiring him to persevere during rough times. The badminton star won three All Africa Champs medals; in singles (bronze), men’s doubles (gold) and in the South African mixed team (bronze). He also competed at the World University Games in Chengdu and played in his first World Champs in Copenhagen (men’s doubles). “If I look back at the past year, it was probably my toughest year yet,” he remarked.

Perseverance in the face of challenges

Desiree Ellis, head coach of Banyana Banyana and guest speaker at the event, stressed the importance of celebrating athletes and their excellence. “This inspires and motivates others,” she said. “It is also encouraging to see that it is not just elite athletes at the Free State Sport Stars who get rewarded but also the school kids.” She encouraged athletes to persevere despite obstacles, imparting a powerful message: “Results are not always going to go your way but keep going. Keep going and make sure you keep putting your best foot forward.”

Jerry Laka, Director of KovsieSport, expressed pride in the recognition of UFS athletes, highlighting the unique blend of student-athlete awards and school awards in this event, which serves as a beacon of inspiration for aspiring young athletes.

The KovsieSport awards stand as a testament to the dedication and perseverance of Nketsa and Summers. Their achievements not only inspire the fraternity but also underscore the spirit of resilience and excellence within the UFS community. As these outstanding athletes continue to break barriers and achieve greater heights, they epitomise the spirit of sporting prowess and determination. Congratulations to both Nketsa and Summers on their well-deserved recognition and to all award recipients in the various categories.

Free State Sport Stars 2023

KovsieSport crowned its leading junior sports stars. The triple jump athlete Johani van Tonder was named Junior Sportswoman of the Year and the Junior Springbok Michael Annies as Junior Sportsman of the Year. Here, from the left are, Van Tonder, Jerry Laka, Director of KovsieSport, Jeannine van Zyl, General Manager of Central24, and Annies.

News Archive

Cardiology Unit involved in evaluation of drug for rare genetic disease

2013-01-04

Front from the left, are: Marinda Karsten (study coordinator and registered nurse),
Laumarie de Wet (clinical technologist), Charmaine Krahenbuhl (study coordinator and radiographer),
Lorinda de Meyer (administrator), Andonia Page (study coordinator and enrolled nurse);
back Dr Gideon Visagie (sub investigator), Dr Derick Aucamp (sub investigagtor),
Prof. Hennie Theron, (principal investigator) and Dr Wilhelm Herbst (sub investigator).
Photo: Supplied
09 January 2013

The Cardiology Research Unit at the University of the Free State (UFS) contributed largely to the evaluation of the drug Juxtapid (lomitapide), which was developed by the Aegerion pharmaceutical company and approved by the FDA (Federal Drug Administration). Together with countries such as die USA, Canada and Italy, the UFS’ Unit recruited and evaluated the most patients (5 of 29) for the study since 2008.

The drug was evaluated in persons with so-called familial homozygous hypercholesterolemia (HoFH).

Following its approval by the FDA, Juxtapid is now a new treatment option for patients suffering from HoFH. The drug operates in a unique way which brings about dramatic improvements in cholesterol counts.

According to Prof. Hennie Theron, Associate Professor in the Department of Cardiology at the UFS and Head of the Cardiology Contract Research Unit, HoFH is a serious, rare genetic disease which affects the function of the receptor responsible for the removal of low-density lipoprotein cholesterol (LDL-C) (“bad” cholesterol) from the body. Damage to the LDL receptor function leads to extremely high levels of blood cholesterol. HoFH patients often develop premature and progressive atherosclerosis, which is a narrowing or blockage of the arteries.

“HoFH is a genetically transmitted disease and the most severe form of hypercholesterolemia. Patients often need a coronary artery bypass or/and aortic valve replacement before the age of 20. Mortality is extremely high and death often occurs before the third decade of life. Existing conventional cholesterol-lowering medication is unsuccessful in achieving normal target cholesterol values in this group of patients.

“The only modality for treatment is plasmapheresis (similar to dialysis in patients with renal failure). Even with this type of therapy the results are relatively unsatisfactory because it is very expensive and the plasmapheresis has to be performed on a regular basis.

“The drug Juxtapid, as currently evaluated, has led to a dramatic reduction in cholesterol values and normal values were achieved in several people. No existing drug is nearly as effective.

“The drug represents a breakthrough in the treatment of familial homozygous hypercholesterolemia. The fact that it has been approved by the FDA, gives further impetus to the findings,” says Prof. Theron.

In future further evaluation will be performed in other forms of hypocholesterolemia.

According to Prof. Theron, the findings of the study, as well as the recent successful FDA evaluation, once again confirms the fact that the UFS’ Cardiology Contract Research Unit is doing outstanding work.

Since its inception in 1992, the Unit has already been involved in more than 60 multi-centre, international phase 2 and 3 drug studies. Several of these studies, including the abovementioned study, really affected the way in which cardiology functions.

The UFS’ Cardiology Contract Research Unit is being recognised nationally and internationally for its high quality of work and is constantly approached for their involvement in new studies.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept